Kinases, homology models, and high throughput docking

被引:109
作者
Diller, DJ [1 ]
Li, RX [1 ]
机构
[1] Pharmacopeia Inc, Princeton, NJ 08543 USA
关键词
D O I
10.1021/jm020503a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
With the many protein sequences coming from the genome sequencing projects, it is unlikely that we will ever have an atomic resolution structure of every relevant protein. With high throughput crystallography, however, we will soon have representative structures for the vast majority of protein families. Thus the drug discovery and design process will rely heavily on protein modeling to address issues such as designing combinatorial libraries for an entire class of targets and engineering genome-wide selectivity over a target class. In this study we assess the value of high throughput docking into homology models. To do this we dock a database of random compounds seeded with known inhibitors into homology models of six different kinases. In five of the six cases the known inhibitors were found to be enriched by factors of 4-5 in the top 5% of the overall scored and ranked compounds. Furthermore, in the same five cases the known inhibitors were found to be enriched by factors of 2-3 in the top 5% of the scored and ranked known kinase inhibitors, thus showing that the homology models can pick up some of the crucial selectivity information.
引用
收藏
页码:4638 / 4647
页数:10
相关论文
共 77 条
[71]   Structural basis of inhibitor selectivity in MAP kinases [J].
Wang, ZL ;
Canagarajah, BJ ;
Boehm, JC ;
Kassisa, S ;
Cobb, MH ;
Young, PR ;
Abdel-Meguid, S ;
Adams, JL ;
Goldsmith, EJ .
STRUCTURE, 1998, 6 (09) :1117-1128
[72]  
WINDER WW, 2000, DIABETES TECHNOL THE, P441
[73]   4-Anilino-6,7-dialkoxyquinolime-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors [J].
Wissner, A ;
Berger, DM ;
Boschelli, DH ;
Floyd, MB ;
Greenberger, LM ;
Gruber, BC ;
Johnson, BD ;
Mamuya, N ;
Nilakantan, R ;
Reich, MF ;
Shen, R ;
Tsou, HR ;
Upeslacis, E ;
Wang, YF ;
Wu, BQ ;
Ye, F ;
Zhang, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (17) :3244-3256
[74]   Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation [J].
Yamaguchi, H ;
Hendrickson, WA .
NATURE, 1996, 384 (6608) :484-489
[75]  
Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261
[76]   Potent and selective inhibitors of the Abl-kinase: Phenylamino-pyrimidine (PAP) derivatives [J].
Zimmermann, J ;
Buchdunger, E ;
Mett, H ;
Meyer, T ;
Lydon, NB .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (02) :187-192
[77]   Phenylamino-pyrimidine (PAP) - derivatives: A new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors [J].
Zimmermann, J ;
Buchdunger, E ;
Mett, H ;
Meyer, T ;
Lydon, NB ;
Traxler, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (11) :1221-1226